Alterity Therapeutics Limited
ATH
Ранг среди акций
#25695
Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997,... Based in Melbourne, Australia, Alterity Therapeutics Limited, founded in 1997, is dedicated to the discovery and advancement of treatments for neurological conditions such as Alzheimer's, Huntington's, and Parkinson's diseases, among others. The company's primary drug candidate, ATH434, has successfully navigated Phase I clinical trials for Parkinson's disease. Additionally, it is progressing PBT2, an investigational compound for Alzheimer's disease that has completed Phase 2a clinical trials. The firm, previously known as Prana Biotechnology Limited, adopted its current name, Alterity Therapeutics Limited, in April 2019.
Цена акции
$0.20453259
Рыночная капитализация
$44.69M
Изменение (1 день)
1.75%
Изменение (1 год)
-41.56%
Страна
AU
Торговля Alterity Therapeutics Limited (ATH)
Категория
Healthcare
EPS для Alterity Therapeutics Limited (ATH)
EPS по состоянию на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Alterity Therapeutics Limited, текущий EPS компании (TTM) составляет 0. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании Alterity Therapeutics Limited с 2026 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| Недостаточно данных для указанных дат. | ||
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| - | - |
CH
|
|
| $27.74 | - |
NL
|
